The objective of this study was to evaluate the effect of implanting an Antigen Release Devices (ARD) into dairy cows during the lactation cycle to induce an immune response. Subsequently, the concentrations of lactoferrin in serum and milk were measured. Forty healthy adult Chinese Holstein cows were divided into two equal groups: a test group and a control group. Animals in the test group received ARD implants, whereas the control group animals were not treated. An even spread across the two groups was maintained with animal selection based on parity, the lactation days and milk yields. The concentrations of lactoferrin in the serum and milk of all forty animals were measured using an Enzyme-Linked Immunosorbent Assay (ELISA). The results show that the implantation of an ARD did not significantly increase the concentration of lactoferrin in the serum and milk throughout the whole experiment period except on two occasions. The levels of lactoferrin in the milk and serum significantly increased on day 7 and on day 11 after implantation (p<0.05). There was a strong correlation between milk lactoferrin and serum lactoferrin (r=0.564, P<0.01). Three separate ARDs were used releasing its antigen load on day 0, 14 and 28 to induce a primary, secondary and tertiary response respectively. As the significant increases in the lactoferrin levels were only observed after the first ARD release, the effects of lactoferrin appears to be associated with the early phase of the immune response, consistent with its role in the host's innate defense system.
Lactoferrin is an iron-binding glycoprotein synthesized by specific granules in polymorphonuclear leukocytes (PMNL) [2] and glandular epithelial cells [13] . This 80 kilodalton protein is a member of the transferrin family of proteins, which includes members such as melanotransferrin and ovotransferin. Lactoferrin is present in milk and other secretions such as tears and saliva, which coat mucosal surfaces [19] . Lactoferrin is a key element of the host's innate defense system. It has antimicrobial properties, which include iron sequestration, direct lytic activities, as well as the ability to impair the binding of microbes to host cells [24] . Over the years, a number of reports have suggested that lactoferrin has a wide range of effects on the immune system, both in vivo and in vitro [3, 9, 24] . However, it has been difficult to identify a clear trend, as most observations have failed to reveal clues to the underlying mechanism. Many immunological mechanisms are critically dependent upon cell-cell interactions, with the number and affinity of interactions between two cells affecting the nature of downstream events. Lactoferrin's ability to bind cell surfaces is likely to affect these downstream events, and could thus alter the immune response.
In the body, lactoferrin is secreted in an iron-free form from epithelial cells into most exocrine fluids, in particular milk [15] . The protein is major component of the secondary granules of neutrophils [8, 14] . In some pathologies, inflammation can increase the levels of lactoferrin in biological fluids. This is particularly noticeable in the circulation with elevated levels shown in plasma. Therefore, through the monitoring of lactoferrin levels in the serum and milk any physiological changes, including infection, can be detected.
The function of lactoferrin on the immune system of dairy cows was of particular interest in this study. The working hypothesis speculates that the body in a hyperimmune state correlates with an increase in the concentration of lactoferrin. Few reports demonstrate changes of lactoferrin concentration in serum and milk while an animal is under immune stress. In this study, implantation of an Antigen Release Device (ARD) was used in cows to induce an immune response in order to determine the levels of lactoferrin in serum and milk.
MATERIALS AND METHODS
Immune method: Antigen Release Devices were provided by, Agri-BIOTECH (Perth, Western Australia). The ARD comprised a core formulation of the antigen (Lipoprotein Lipase of Pseudomonas sp, Sigma, St. Louis, MO, U.S.A.) with Quil-A as an adjuvant. The core formulation was coated with a polylactic-glycosidic polymer, which dissolves to produce the byproducts CO 2 and water. A series of three ARDs, each with different release times were implanted subcutaneously along the hind leg fascia in close proximity to the supramammary lymph node. ARD1 corresponding to the release of antigen on day 0, ARD2 to day 14 and ARD3 to day 28.
Cows, husbandry and feeding: Forty healthy adult Holstein dairy cows were divided into 2 groups according to the equation of parity (test group -2.65 ± 0.67; control group -2.65 ± 0.59), the lactation day (test group -114.6 ± 31.6 days; control group -112.6 ± 35.6 days) and day milk yield (test group -25.3 ± 3.3 kg; control group -26.6 ± 3.7 kg). Also included, the criteria that animals selected showed no signs of mastitis (such as redness, swelling, hardness and pain in the udder, or the presence of clots in the milk) for at least 2 months. The test group cows were implanted with three ARDs. All the cows were housed identically, and their diets were mixed and fed as Total mixed ration (TMR) three times a day.
Milk samples: From each animal, duplicate milk samples were collected at the times 09:00, 16:00 and 22:00 on each day of sampling. The first set of milk samples (50 ml) from each milking was preserved with bronopol-B2 and subsequently analyzed for fat, protein, lactose, total solid and somatic cell count (SCC) using a MilkoScan Minor machine (MilkoScan 4000, Foss Electric, Hillerod, Denmark). The second set of milk sample (30 ml) from each individual cow was pooled to make up a daily sample according to milk yield. Fat was removed from the pooled sample by centrifugation at 10,000 × g for 15 min at 4°C (Sorvall. legend black mach 1.6 R., Germany). The resultant skim milk was frozen at -80°C for further analysis of lactoferrin levels.
Blood samples: Two separate blood samples were taken from the cordal vein of each animal (n=10) in evacuated tubes containing EDTA (1.8 g/l of blood). One set of the samples was centrifuged (30 min at 3,000 × g) to separate serum. The other set was used to detect the number of white blood cell (WBC), lymphocyte (LYMPH), Agranulocyte (GRAN) and mid-cell (MID), using an automatic blood cell counter (Celltac-α MEK-6318, Nippon Koden Inc.).
Quantitative determination of specific lipoprotein lipase antibody and lactoferrin concentration: The levels of specific Lipoprotein Lipase antibody in the serum and skimmed milk samples were measured using an indirect enzymelinked immunosorbent assay (ELISA). Lipase antigen (Sigma Chemical Co., St. Louis, MO), diluted in calcium carbonate buffer (25 µg/ml), was coated onto hi-binding 96 well ELISA plates and incubated at 4°C overnight. The plates were then washed 4 times with 1 × PBS containing 0.5% Tween 20. Skim milk and serum samples were diluted to 1:2,000 and 1:10,000 respectively and incubated on the lipase coated plate for 90 min at 37°C. After washing the plate four times with 1 × PBS + 0.5% Tween 20, an alkaline phosphatase conjugated antibody, donkey anti-goat whole Ig AP (Promega), was placed on to the plate and incubated at 37°C for 90 min. Subsequently after washing four times with 1 × PBS + 0.5% Tween 20, the substrate nitrophenyl phosphate in Diethanolamine buffer (1:100) was incubated on the plate at room temperature for approximately 20 min. The colorimetric reaction was stopped with 3.75M NaOH and read using an ELISA plate-reader (Infinite F200) at 450 nm.
Quantitative determination of lactoferrin was performed using a commercial ELISA [22] , Bovine lactoferrin Quantitation Kit (Bethyl Laboratories, Inc., Montgomery, TX, U.S.A.). The final absorbance of the samples was measured at 450 nm, using an ELISA plate-reader (Infinite F200; Tecan, Switzerland). The ELISA procedure was performed according to the manufacturer's instructions.
Statistical analysis: The data for the lactoferrin concentration in the serum and milk were analyzed as a completely randomized design with repeated measures using the MIXED models of SAS [20] . Fixed effects included treatment, period, and treatment × period interaction. The correlation coefficients among indices were analyzed by Pearson's correlation coefficient. Because the variances were not homogeneous, the measurements of SCC, WBC, LYMPH, MID and GRAN were transformed into logarithmic form to attain a normal distribution of values. A "P value" of less than 0.05 was considered significant, less than 0.01 was considered highly significant.
RESULTS
The levels of specific lipoprotein lipase antibody in the serum and milk: The level of specific lipoprotein lipase antibody in the serum and milk is shown in Figs. 1 and 2. We observed respectively a high level of specific lipoprotein lipase antibody in the serum after implantation, which persisted to day 40 ( Fig. 1 ). The first instance of the specific lipoprotein lipase antibody found in the milk was on day 9, and high levels persisted from days 17 to 40 ( Fig. 2 ). Interestingly, the regulation of the antibody response was associated with the three ARD release times.
Lactoferrin content in the serum: Serum lactoferrin concentration in the test group cows and control group cows ranged from 0.508 to 1.728 µg/ml (n=70) and from 0.493 to 0.980 µg/ml (n=70), respectively. The 95% confidence range (mean ± standard deviation) for the serum lactoferrin concentration in normal lactation cow was between 0.639 µg/ml and 0.861 µg/ml and the mean concentration was 0.735 µg/ml. The results of lactoferrin content in the serum were tabulated (Table 1) . On average, the implantation of the encapsulated antigen did not elevate the serum concentration of lactoferrin during the whole experimental period (P>0.05). However, the mean lactoferrin concentration of the test group cows on day 11 was significantly greater (P<0.05) than those in the control group cows. The lactoferrin concentration increased from 0.694 µg/ml on day 0 to a peak of 0.903 µg/ml on day 15. In comparison with test group day 0 samples, lactoferrin concentrations on days 11 and 15 were significantly greater (P<0.05) ( Table 1) . However, the mean lactoferrin concentration between the control group animals on the same days deviated only slightly on day 15 and was found not to be significant.
Lactoferrin content in the milk: Milk lactoferrin concentrations in the test group cows and control group cows ranged from 0.036 to 0.820 mg/ml (n=200) and from 0.039 to 0.363 mg/ml (n = 200), respectively. The 95% confidence range (mean ± standard deviation) for the milk lactoferrin concentration in normal lactating cows was between 0.150 mg/ml and 0.260 mg/ml, with the mean concentration being 0.207 mg/ml. Generally, concentrations of lactoferrin in the milk were not significantly affected by the implantation of ARDs during the whole experiment period (P>0.05), but there was a significant period effect (P<0.05) ( Table 1 ). In the test group cows, mean lactoferrin concentrations increased significantly (P<0.01) from day 0 values of 0.192 mg/ml to a peak of 0.313 mg/ml on day 7. This dramatic change was found to be significant when compared with the control group cows (P<0.05). There was an almost linear decline in lactoferrin content from day 7 to 0.198 mg/ml on day 15. By days 17 and 20, there was also an increase of lactoferrin concentration, but this change was not significant (P>0.05). However, the milk lactoferrin concentration in the control group cows did not show significant change (P>0.05).
The correlation between serum lactoferrin content, white blood cell, lymphocyte, granulocyte and mid-cell: In this study, white blood cell, lymphocyte, and mid-cell of the test group increased after implantation (P<0.05). The numbers of granulocytes showed little increase in the test group cows, on days 5, 15 and 32, which almost correspond with the three ARD release times. However, there was no significant difference of the number of granulocytes (P>0.05) in the 2 groups. Serum lactoferrin was not correlated with white blood cell, lymphocyte, granulocyte and mid-cell in both test group cows and control group cows (P>0.05).
The correlation between milk components (milk lactoferrin content, fat, protein, lactose and total solid), serum lactoferrin content,and somatic cell count: There were no obvious difference for milk components and somatic cell counts between test group and control group (P>0.05). Compared to the control group cows, the mean milk protein percent in test group cows showed little decrease on day 10 and returned to a normal level before day 15. There was also an increase on days 20, 32 and 39, respectively, but there was no significant difference (P>0.05). Milk lactoferrin levels were significantly related to serum lactoferrin levels (r=0.564, P<0.01, Fig. 3 ) in the test group cows, but not in the control group cows (r=0.147, P>0.05).
DISCUSSION
The immuno-stimulating complex (ISCOM) is a potent mucosal and parenteral adjuvant and delivery vehicle, enhancing both system and mucosal immune responses [7] . In this study, the levels of specific lipoprotein lipase antibody in the serum and milk suggest that the implantation of an ARD is an efficient method to immunize cows to produce a persistent and controlled immune response with high titres of specific antibodies. In fact, the levels of specific lipoprotein lipase antibody in the serum and milk should have the same trend, as the specific lipoprotein lipase antibody in the milk was presumably transferred from the blood. However, we did not find the decline of the level of specific lipoprotein lipase antibody in the serum. This unrelated change may be a result of the sampling days. The sampling days of blood were 0, 5, 11, 15, 20, 32 and 39, while the sampling days of milk were 0, 3, 5, 7, 9, 11, 13, 15, 17, 20, 23, 26, 29, 32, 35 and 39. Lactoferrin concentration in the serum can be as low as 0.4 to 2 µg/ml under normal conditions, but can increase to 0.2 mg/ml in septicemia [11] . In fact, most neutrophilic lactoferrin is delivered by PMNL to the sites of inflammation. In this study, a concentration of 0.735 µg/ml (lactoferrin) was shown in normal lactating cows. The implantation of the ARDs significantly elevated the level of lactoferrin concentration on day 11 in the serum (P<0.05). Masson et al. [14] reported that lactoferrin had been isolated from human PMNL at a concentration of 3.0 µg/10 6 cells. In this study, the numbers of granulocytes showed little increase in the test group cows, on days 5, 15 and 32. This almost corresponded with the three ARD release times. However, there was no significant difference in the number of granulocytes (P>0.05) between the two groups. Lactoferrin is expressed on resting PMNL, where it can participate in the binding of microorganisms [4] . Lactoferrin is released on mass from PMNL upon TNF-α and phorbols stimulation, binding to the PMNL membrane [1, 12] . So, this may be the reason for the relationship between serum lactoferrin and granulocyte levels. Lactoferrin has been quantified in milk using different techniques such as capillary electrophoresis [18] and reversed-phase high-performance liquid chromatography [16] . Several immunoassays have been developed for the same purpose. A review of the different immunological techniques available to quantify lactoferrin concentration concluded that immunodiffusion techniques have inherently low sensitivity and have generally been superseded by the more sensitive ELISA techniques [6] . In this study, we chose the Bovine Lactoferrin ELISA Quantification Kit from Bethyl Laboratories and found a milk lactoferrin level of 0.207 mg/ml in normal bovine milk. Our results were similar to previously reported normal milk lactoferrin concentrations during lactation of 250 to 404 µg/ml [5, 25] . The level of milk lactoferrin increased significantly on days 5 and 7 after the implantation of the ARDs (P<0.05, P<0.01, respectively), suggesting that increased levels of lactoferrin in the serum and milk may be associated with the early phase of the immune response.
The milk lactoferrin concentration had a strong correla- tion to serum lactoferrin (r=0.564, P<0.01) and milk protein (r=0.385, P<0.01) in the test group cows. To our knowledge, no data showing the correlation between serum lactoferrin content and milk lactoferrin content in bovine have been reported. In this study, we observed a significant correlation of lactoferrin concentrations between serum and milk (Fig. 3) . The positive correlation between lactoferrin in serum and milk indicated that the elevated milk lactoferrin concentration might accompany high levels of serum lactoferrin in the same animal; however, it cannot be assumed that they changed at the same rate or at the same time. Therefore, it was likely that PMNL is the source of lactoferrin in milk during an increased immune state. Monitoring for changes in lactoferrin levels of serum and milk is useful to detect any physiological change or infection in mammals. As we know, epithelial cells in the bovine mammary gland produce lactoferrin. Steady-state levels of bovine lactoferrin mRNA (by Northern blot) in the bovine mammary gland indicate that bovine lactoferrin expression is minimal in the developing and lactating gland but is strongly induced by mammary involution. In addition to the acute up-regulation of lactoferrin mRNA at involution, its low levels in tissue during lactation may also result from active down-regulation of lactoferrin expression [21] . Furthermore, the lactoferrin regulation in different mammary states may involve gene methylation. It is reported that different methylation patterns exist for the lactoferrin gene in leukemia and breast cancer cases [17] . Lactoferrin clearly shows an overall expression contrary to that for the other milk proteins, which probably results from both transcriptional and posttranscriptional regulation [21] .
It was reported that oral bovine lactoferrin acted initially on the intestinal immune system and then promote systemic protective immunity as a secondary effect [23] . In this study, the findings that lactoferrin concentration increases sharply in the early stage of the immune response, together with the reported effects on the immune system [3, 9, 24] indicate that lactoferrin may have an important role in the protection of dairy cows from infection. The increase of serum lactoferrin levels may partly contribute to the elevation of the milk lactoferrin concentration, and that epithelial cells may be another source of lactoferrin in the milk during a hyper-immune state. However, the underlying mechanism of the increasing of the milk lactoferrin content needs further study.
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